Liraglutide
Peptide therapy: benefits, side effects, cost and protocols
C172H265N43O51
Liraglutide, sold under the brand names Victoza and Saxenda, is a GLP-1 receptor agonist used to treat type 2 diabetes and chronic obesity. It is given by subcutaneous injection and was one of the first GLP-1 agonists approved for weight management.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- Lowest listed
- $179/mo
- FDA status
- FDA-approved drug
- Evidence
- Strong Evidence
Price sheet
Liraglutide prices, lowest first
2 listings, $179 to $299 per month.
We may earn a commission at no extra cost to you. Disclosure
| Provider | Per month | Link |
|---|---|---|
Henry Meds Generic Liraglutide / daily injection ClinicalRx | $179Lowest | Visit |
HimsOut of stock Generic Liraglutide / [unverifiable on public site Jul 2026] 503A CompoundedClinical | $299 | Visit |
Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.
Who it's for
Who Liraglutide is usually considered for
- Weight management
- Blood sugar regulation
- Cardiovascular risk reduction
- Appetite suppression
- Phase 4
Mechanism
How Liraglutide works
GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.
Evidence
Key studies
6,055 papers on PubMed
- 01
Liraglutide and Renal Outcomes in Type 2 Diabetes
- 02
Mann JFE, Ørsted DD, Brown-Frandsen K et al
N Engl J Med / RCT
- 03
Liraglutide reduced risk of diabetic kidney disease progression and macroalbuminuria development
- 04
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- 05
Marso SP, Daniels GH, Brown-Frandsen K et al
N Engl J Med / RCT
- 06
Liraglutide reduced cardiovascular death, MI, or stroke by 13% in type 2 diabetes
- 07
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes
- 08
GRADE Study Research Group, Nathan DM, Lachin JM et al
N Engl J Med / RCT
Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c.
- 09
Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c
- 10
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Compound
Liraglutide compound data
- Formula
- C172H265N43O51
- Mol. weight
- 3751 g/mol
- PubChem CID
- 16134956 ↗
- IUPAC
- (2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-5-oxo-pentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(1S)-1-[[(1S)-1-benzyl-2-[[(1S,2S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[2-[[(1S)-1-(carboxymethylcarbamoyl)-4-guanidino-butyl]amino]-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]amino]-6-oxo-hexyl]amino]-2-(hexadecanoylamino)-5-oxo-pentanoic acid
FAQ
Liraglutide questions
What is LIRAGLUTIDE?
Liraglutide is a first-generation GLP-1 receptor agonist used for weight management (Saxenda) and type 2 diabetes (Victoza). Developed by Novo Nordisk, it requires daily injection and has shown cardiovascular risk reduction benefits.
How does LIRAGLUTIDE work?
GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.
Is LIRAGLUTIDE legal to buy?
LIRAGLUTIDE requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.
Where can I buy LIRAGLUTIDE?
LIRAGLUTIDE is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.
What category does LIRAGLUTIDE belong to?
LIRAGLUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of LIRAGLUTIDE?
LIRAGLUTIDE has been studied for: Weight management, Blood sugar regulation, Cardiovascular risk reduction, Appetite suppression. First-generation daily GLP-1 agonist. Marketed as Saxenda (weight loss) and Victoza (diabetes).
News
Liraglutide in the news
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis - Nature
Nature / 58 months ago
Could one daily pill narrow the diabetes treatment gap in the Global South? - Al Jazeera
Al Jazeera / 7 days ago
Comparing Ozempic, Wegovy and Other GLP-1 Drugs - GoodRx
GoodRx / 48 months ago
GLP-1 Agonists Show Weight Benefits in Adults but Lack Pediatric Antipsychotic Trials - Bioengineer.org
Bioengineer.org / 1 day ago
Narrative Review Explores Shared Biological Pathways Linking Obesity and Migraine Progression - Bioengineer.org
Bioengineer.org / 1 day ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Liraglutide?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.